These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21725185)

  • 1. Relationship between serum parathyroid hormone and hypertension in hemodialysis patients.
    Sedighi O; Makhlough A; Kashi Z; Zahedi M
    Iran J Kidney Dis; 2011 Jul; 5(4):267-70. PubMed ID: 21725185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and severity of anemia in pediatric hemodialysis patients.
    Azhir A; Nasiri J; Gheisari A
    Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased resting energy expenditure in hemodialysis patients with severe hyperparathyroidism.
    Cuppari L; de Carvalho AB; Avesani CM; Kamimura MA; Dos Santos Lobão RR; Draibe SA
    J Am Soc Nephrol; 2004 Nov; 15(11):2933-9. PubMed ID: 15504947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal changes of parathyroid hormone in chronic hemodialysis patients.
    Thang NT; Yamaguchi O; Yoshimura Y; Shiraiwa Y; Kumagai I
    Fukushima J Med Sci; 1993 Jun; 39(1):29-33. PubMed ID: 8125427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism.
    Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Rodriguez AP; Felsenfeld AJ
    J Bone Miner Res; 1997 Mar; 12(3):347-55. PubMed ID: 9076577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in a hemodialysis population.
    Jalalzadeh M; Mohammadi R; Mirzamohammadi F; Ghadiani MH
    Iran J Kidney Dis; 2011 Jul; 5(4):248-54. PubMed ID: 21725182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients.
    Borràs M; Torregrossa V; Oliveras A; Almirall J; Ma Paz M; Betriu A; Martin M; Muray S; Fibla J; Fernández E
    J Nephrol; 2003; 16(1):116-20. PubMed ID: 12649542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary hyperparathyroidism: incidence, clinical presentations, treatment].
    Samokhvalova NA; Romanchishen AF; Gerasimchuk RP; Grinev KM; Zemchenkov AIu
    Vestn Khir Im I I Grek; 2007; 166(5):78-81. PubMed ID: 18154100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.
    Lippuner K; Zehnder HJ; Casez JP; Takkinen R; Descoeudres C; Jaeger P
    Nephrol Dial Transplant; 1996 Jan; 11(1):70-4. PubMed ID: 8649655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.